Is incentive spirometry beneficial for patients with lung cancer receiving video-assisted thoracic surgery?
Age Distribution
Aged
Databases, Factual
Emergency Service, Hospital
/ statistics & numerical data
Female
Hospitalization
/ economics
Humans
Incidence
Linear Models
Lung Neoplasms
/ epidemiology
Male
Middle Aged
Multivariate Analysis
Pneumonia
/ epidemiology
Postoperative Complications
/ epidemiology
Respiratory Function Tests
Sex Distribution
Spirometry
Taiwan
/ epidemiology
Thoracic Surgery, Video-Assisted
/ adverse effects
Thoracotomy
/ adverse effects
Time Factors
Treatment Outcome
Incentive spirometry
Lung cancer
Video-assisted thoracic surgery (VATS)
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
08 Jul 2019
08 Jul 2019
Historique:
received:
15
11
2018
accepted:
24
06
2019
entrez:
10
7
2019
pubmed:
10
7
2019
medline:
9
1
2020
Statut:
epublish
Résumé
The effectiveness of Incentive spirometry (IS) in patients undergoing video-assisted thoracic surgery (VATS) remains lacking. We conducted a population-based study to investigate the effectiveness of IS on patients with lung cancers following VATS. We identified patients newly diagnosed with lung cancer who underwent surgical resection by VATS or thoracotomy from the years 2000 to 2008 in the Longitudinal Health Insurance Database. Exposure variable was the use of IS during admission for surgical resection by VATS or thoracotomy. Primary outcomes included hospitalization cost, incidence of pneumonia, and length of hospital stay. Secondary outcomes included the frequency of emergency department (ED) visits and hospitalizations at 3-month, 6-month, and 12-month follow-ups after thoracic surgery. We analyzed 7549 patients with lung cancer undergoing surgical resection by VATS and thoracotomy. The proportion of patients who were subjected to IS was significantly higher in those who underwent thoracotomy than in those who underwent VATS (68.4% vs. 53.1%, P < 0.0001). After we controlled for potential covariates, the IS group significantly reduced hospitalization costs (- 524.5 USD, 95% confidence interval [CI] = - 982.6 USD - -66.4 USD) and the risk of pneumonia (odds ratio = 0.55, 95% CI = 0.32-0.95) compared to the non-IS group following VATS. No difference in ED visit frequency and hospitalization frequency at 3-month, 6-month, and 1-year follow-up was noted between the IS and the non-IS groups following VATS. The use of IS in patients with lung cancers undergoing VATS may reduce hospitalization cost and the risk of pneumonia.
Sections du résumé
BACKGROUND
BACKGROUND
The effectiveness of Incentive spirometry (IS) in patients undergoing video-assisted thoracic surgery (VATS) remains lacking. We conducted a population-based study to investigate the effectiveness of IS on patients with lung cancers following VATS.
METHODS
METHODS
We identified patients newly diagnosed with lung cancer who underwent surgical resection by VATS or thoracotomy from the years 2000 to 2008 in the Longitudinal Health Insurance Database. Exposure variable was the use of IS during admission for surgical resection by VATS or thoracotomy. Primary outcomes included hospitalization cost, incidence of pneumonia, and length of hospital stay. Secondary outcomes included the frequency of emergency department (ED) visits and hospitalizations at 3-month, 6-month, and 12-month follow-ups after thoracic surgery.
RESULTS
RESULTS
We analyzed 7549 patients with lung cancer undergoing surgical resection by VATS and thoracotomy. The proportion of patients who were subjected to IS was significantly higher in those who underwent thoracotomy than in those who underwent VATS (68.4% vs. 53.1%, P < 0.0001). After we controlled for potential covariates, the IS group significantly reduced hospitalization costs (- 524.5 USD, 95% confidence interval [CI] = - 982.6 USD - -66.4 USD) and the risk of pneumonia (odds ratio = 0.55, 95% CI = 0.32-0.95) compared to the non-IS group following VATS. No difference in ED visit frequency and hospitalization frequency at 3-month, 6-month, and 1-year follow-up was noted between the IS and the non-IS groups following VATS.
CONCLUSIONS
CONCLUSIONS
The use of IS in patients with lung cancers undergoing VATS may reduce hospitalization cost and the risk of pneumonia.
Identifiants
pubmed: 31286923
doi: 10.1186/s12890-019-0885-8
pii: 10.1186/s12890-019-0885-8
pmc: PMC6615301
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
121Subventions
Organisme : Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence
ID : MOHW105-TDU-B-212-133019
Références
Respir Care. 1991 Dec;36(12):1402-5
pubmed: 10145589
Ann Thorac Surg. 2000 Sep;70(3):938-41
pubmed: 11016337
Ann Thorac Surg. 2000 Nov;70(5):1644-6
pubmed: 11093502
Chest. 2002 Aug;122(2):584-9
pubmed: 12171836
Respirology. 2005 Jun;10(3):349-53
pubmed: 15955148
Ann Intern Med. 2006 Apr 18;144(8):596-608
pubmed: 16618957
Interact Cardiovasc Thorac Surg. 2008 Apr;7(2):297-300
pubmed: 18039692
Ann Thorac Surg. 2008 Jan;85(1):231-5; discussion 235-6
pubmed: 18154816
Ann Thorac Surg. 2008 Dec;86(6):2008-16; discussion 2016-8
pubmed: 19022040
Eur J Cardiothorac Surg. 2009 Mar;35(3):423-8
pubmed: 19136272
J Thorac Cardiovasc Surg. 2009 Jul;138(1):11-8
pubmed: 19577048
Cochrane Database Syst Rev. 2009 Jul 08;(3):CD006058
pubmed: 19588380
World J Surg. 2009 Sep;33(9):1857-61
pubmed: 19626361
Surg Endosc. 2011 Apr;25(4):1054-61
pubmed: 20835729
Ann Thorac Surg. 2011 Dec;92(6):1943-50
pubmed: 21962268
Respir Care. 2011 Oct;56(10):1600-4
pubmed: 22008401
Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004466
pubmed: 22972072
Cochrane Database Syst Rev. 2012 Nov 14;11:CD010118
pubmed: 23152283
Physiotherapy. 2013 Sep;99(3):187-93
pubmed: 23206316
Physiotherapy. 2013 Jun;99(2):119-25
pubmed: 23219632
Thorax. 2013 Jun;68(6):580-5
pubmed: 23429831
Eur J Cardiothorac Surg. 2013 Jul;44(1):e71-6
pubmed: 23509236
Chest. 2013 May;143(5 Suppl):e278S-e313S
pubmed: 23649443
Ann Thorac Surg. 2013 Sep;96(3):951-60; discussion 960-1
pubmed: 23866808
Lancet. 2013 Aug 24;382(9893):709-19
pubmed: 23972814
J Thorac Dis. 2013 Aug;5 Suppl 3:S190-3
pubmed: 24040522
Eur J Cardiothorac Surg. 2014 Apr;45(4):640-5
pubmed: 24052605
Cochrane Database Syst Rev. 2014 Feb 08;(2):CD006058
pubmed: 24510642
Anaesthesia. 2014 Aug;69(8):891-8
pubmed: 24845198
Nat Rev Cancer. 2014 Aug;14(8):535-46
pubmed: 25056707
Int J Clin Pract. 2015 Jun;69(6):682-8
pubmed: 25421905
J Thorac Dis. 2014 Dec;6(12):1690-6
pubmed: 25589961
Eur J Cardiothorac Surg. 2016 Feb;49(2):602-9
pubmed: 25913824
Eur J Cardiothorac Surg. 2016 Mar;49(3):870-5
pubmed: 26088592
Ann Surg Oncol. 2016 Jun;23(6):2094-8
pubmed: 26847683
Perioper Med (Lond). 2016 May 23;5:10
pubmed: 27222707
PLoS One. 2016 Nov 18;11(11):e0163809
pubmed: 27861490
Physiotherapy. 2017 Mar;103(1):1-12
pubmed: 27931870
Ann Thorac Surg. 2018 Aug;106(2):340-345
pubmed: 29702071
Chest. 1988 May;93(5):946-51
pubmed: 3359849
Chest. 1997 Mar;111(3):559-63
pubmed: 9118687